Heptinstall S, May J, Fox S, Kwik-Uribe C, Zhao L Cocoa flavanols and platelet and leukocyte function: recent in vitro and ex vivo studies in healthy adults. J Cardiovasc Pharmacol. 2006;47 Suppl 2:S197-205; discussion S206-9.
Hubbard GP, Wolffram S, de Vos R, Bovy A, Gibbins JM, Lovegrove JA Ingestion of onion soup high in quercetin inhibits platelet aggregation and essential components of the collagen-stimulated platelet activation pathway in man: a pilot study. Br J Nutr. 2006 Sep;96(3):482-8.
Hubbard GP, Wolffram S, Lovegrove JA, Gibbins JM Ingestion of quercetin inhibits platelet aggregation and essential components of the collagen-stimulated platelet activation pathway in humans. J Thromb Haemost. 2004 Dec;2(12):2138-45.
Mavrommatis Y, O'Kennedy N, de Roos B et al Effect of eicosapentaenoic acid or docosahexaenoic acid intervention on platelet aggregation: does soluble epoxide hydrolase play a role? unpublished, 2010
Nardini M, Natella F, Scaccini C Role of dietary polyphenols in platelet aggregation. A review of the supplementation studies. Platelets. 2007 May;18(3):224-43. Review.
Natella F, Nardini M, Virgili F, Scaccini C Role of dietary polyphenols in the platelet aggregation network - A review of the in vitro studies. Curr Top Nutraceut Res 4(1): 1-22, 2006.
Ostertag LM, O'Kennedy N, Kroon PA, Duthie GG, de Roos B Impact of dietary polyphenols on human platelet function--a critical review of controlled dietary intervention studies. Mol Nutr Food Res. 2010 Jan;54(1):60-81. doi: 10.1002/mnfr.200900172. Review.
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
